FDA Approves AstraZeneca's (AZN) Iressa for First-line Treatment of Patients with Type of Metastatic Lung Cancer (QGEN)

July 13, 2015 1:31 PM

(Updated - July 13, 2015 1:34 PM EDT)The U.S. Food and Drug Administration today approved Iressa (gefitinib) for the first-line ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found